Product Information
CLOBETASOL 0.05% CREAM is a generic product labeled by Xiromed LLC, priced at $0.1668 per GM under NDC 70700010916. Its NADAC has been published 408 times since Dec 12, 2018.
FDA first approved this application on Jun 15, 2018. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/g
Manufacturer
Xiromed LLCNDC
70700010916
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
CLOBETASOL PROPIONATEApproval Type
Generic (ANDA)
FDA Application
ANDA210034FDA Approved
6/15/2018
TE Code
AB1
On Market Since
6/19/2018
Pharmacological Classes
Price Statistics
The NADAC for CLOBETASOL 0.05% CREAM has been published 408 times since Dec 12, 2018, and over the history we have for it it has declined 83.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1668 per GM |
|---|---|
| All-time high | $1.0366 (Dec 12, 2018) |
| All-time low | $0.1128 (Nov 20, 2024) |
| 52-week high | $0.1780 |
| 52-week low | $0.1668 |
| Median price | $0.2458 |
| Average price | $0.4232 |
| Largest weekly change | +41.2% (Aug 21, 2024) |
| Weeks tracked | 408 |
| Tracking since | Dec 12, 2018 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 31% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Xiromed LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clobetasol Propionate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLOBETASOL 0.05% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for CLOBETASOL 0.05% CREAM, manufactured by Xiromed LLC, is $0.1668 per GM (NDC 70700010916), effective Sep 30, 2026.
How has the price of CLOBETASOL 0.05% CREAM changed over time?
Over the history we have for it, the NADAC for CLOBETASOL 0.05% CREAM has declined 83.9%. It has been tracked across 408 weekly CMS publications since Dec 12, 2018.
What are the highest and lowest recorded NADAC prices for CLOBETASOL 0.05% CREAM?
Since Dec 12, 2018, the NADAC for CLOBETASOL 0.05% CREAM has ranged from a low of $0.1128 (Nov 20, 2024) to a high of $1.0366 (Dec 12, 2018), with a median of $0.2458 per GM.
Are there cheaper alternatives to CLOBETASOL 0.05% CREAM?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLOBETASOL 0.05% CREAM, is $0.1152 per GM — about 31% below CLOBETASOL 0.05% CREAM.
Who manufactures CLOBETASOL 0.05% CREAM?
CLOBETASOL 0.05% CREAM (NDC 70700010916) is labeled by Xiromed LLC, and CMS classifies it as a generic product.